{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:01:13Z","timestamp":1772164873706,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:p>\n                    Obesity is a major risk factor for hypertension. The copresentation of hypertension and insulin resistance (IR) suggests a role for IR in blood pressure (BP) dysregulation. To test this hypothesis, peripheral IR has been genetically subtracted in a model of obesity by crossing leptin receptor mutant mice (K\n                    <jats:sub>db<\/jats:sub>\n                    H\n                    <jats:sub>PTP<\/jats:sub>\n                    ) with mice lacking protein tyrosine phosphatase 1B (insulin desensitizer, H\n                    <jats:sub>db<\/jats:sub>\n                    K\n                    <jats:sub>PTP<\/jats:sub>\n                    ) to generate obese insulin-sensitive mice (K\n                    <jats:sub>db<\/jats:sub>\n                    K\n                    <jats:sub>PTP<\/jats:sub>\n                    ). BP was recorded in lean (H\n                    <jats:sub>db<\/jats:sub>\n                    H\n                    <jats:sub>PTP<\/jats:sub>\n                    , H\n                    <jats:sub>db<\/jats:sub>\n                    K\n                    <jats:sub>PTP<\/jats:sub>\n                    ) and obese (K\n                    <jats:sub>db<\/jats:sub>\n                    H\n                    <jats:sub>PTP<\/jats:sub>\n                    , K\n                    <jats:sub>db<\/jats:sub>\n                    K\n                    <jats:sub>PTP<\/jats:sub>\n                    ) mice via telemetry, and a frequency analysis of the recording was performed to determine BP variability. Correction of IR in obese mice normalized BP values to baseline levels (H\n                    <jats:sub>db<\/jats:sub>\n                    H\n                    <jats:sub>PTP<\/jats:sub>\n                    : 116\u00b12 mm\u2009Hg; K\n                    <jats:sub>db<\/jats:sub>\n                    H\n                    <jats:sub>PTP<\/jats:sub>\n                    : 129\u00b14 mm\u2009Hg; K\n                    <jats:sub>db<\/jats:sub>\n                    K\n                    <jats:sub>PTP<\/jats:sub>\n                    : 114\u00b15 mm\u2009Hg) and restored BP variability by decreasing its standard deviation and the frequency of BP values over the upper autoregulatory limit of the kidneys. However, although IR-induced increases in proteinuria (versus 53\u00b113 \u03bcg\/d, H\n                    <jats:sub>db<\/jats:sub>\n                    H\n                    <jats:sub>PTP<\/jats:sub>\n                    ) were corrected in K\n                    <jats:sub>db<\/jats:sub>\n                    K\n                    <jats:sub>PTP<\/jats:sub>\n                    (112\u00b139 versus 422\u00b1159 \u03bcg\/d, K\n                    <jats:sub>db<\/jats:sub>\n                    H\n                    <jats:sub>PTP<\/jats:sub>\n                    ), glomerular hypertrophy was not. IR reduced plasma aldosterone levels ruling out a role for mineralocorticoids in the development of hypertension. Taken together, these data indicate that correction of IR prevents hypertension, BP variability, and microalbuminuria in obese mice. Although the mechanism remains to be fully determined, increases in aldosterone or sympathoactivation of the cardiovascular system seem to be less likely contributors.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.112.196295","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T01:35:26Z","timestamp":1349746526000},"page":"1273-1279","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Increasing Peripheral Insulin Sensitivity by Protein Tyrosine Phosphatase 1B Deletion Improves Control of Blood Pressure in Obesity"],"prefix":"10.1161","volume":"60","author":[{"given":"Eric J. Belin","family":"de Chantem\u00e8le","sequence":"first","affiliation":[{"name":"From the Vascular Biology Center (E.J.B.d.C., M.I.A., J.D.M., D.J.F., D.W.S), Department of Physiology (E.J.B.d.C., W.E.R., D.W.S.), and Department of Pharmacology (D.J.F.), Georgia Health Sciences University, Augusta, GA; Goodman Cancer Center and Department of Biochemistry, McGill University, Montreal, Quebec, Canada (M.L.T.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Irfan","family":"Ali","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center (E.J.B.d.C., M.I.A., J.D.M., D.J.F., D.W.S), Department of Physiology (E.J.B.d.C., W.E.R., D.W.S.), and Department of Pharmacology (D.J.F.), Georgia Health Sciences University, Augusta, GA; Goodman Cancer Center and Department of Biochemistry, McGill University, Montreal, Quebec, Canada (M.L.T.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Mintz","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center (E.J.B.d.C., M.I.A., J.D.M., D.J.F., D.W.S), Department of Physiology (E.J.B.d.C., W.E.R., D.W.S.), and Department of Pharmacology (D.J.F.), Georgia Health Sciences University, Augusta, GA; Goodman Cancer Center and Department of Biochemistry, McGill University, Montreal, Quebec, Canada (M.L.T.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Rainey","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center (E.J.B.d.C., M.I.A., J.D.M., D.J.F., D.W.S), Department of Physiology (E.J.B.d.C., W.E.R., D.W.S.), and Department of Pharmacology (D.J.F.), Georgia Health Sciences University, Augusta, GA; Goodman Cancer Center and Department of Biochemistry, McGill University, Montreal, Quebec, Canada (M.L.T.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel L.","family":"Tremblay","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center (E.J.B.d.C., M.I.A., J.D.M., D.J.F., D.W.S), Department of Physiology (E.J.B.d.C., W.E.R., D.W.S.), and Department of Pharmacology (D.J.F.), Georgia Health Sciences University, Augusta, GA; Goodman Cancer Center and Department of Biochemistry, McGill University, Montreal, Quebec, Canada (M.L.T.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Fulton","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center (E.J.B.d.C., M.I.A., J.D.M., D.J.F., D.W.S), Department of Physiology (E.J.B.d.C., W.E.R., D.W.S.), and Department of Pharmacology (D.J.F.), Georgia Health Sciences University, Augusta, GA; Goodman Cancer Center and Department of Biochemistry, McGill University, Montreal, Quebec, Canada (M.L.T.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Stepp","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center (E.J.B.d.C., M.I.A., J.D.M., D.J.F., D.W.S), Department of Physiology (E.J.B.d.C., W.E.R., D.W.S.), and Department of Pharmacology (D.J.F.), Georgia Health Sciences University, Augusta, GA; Goodman Cancer Center and Department of Biochemistry, McGill University, Montreal, Quebec, Canada (M.L.T.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000142248.54761.56"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-67-1-48"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111776"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.7.5.702"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-62-6-1302"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602083340607"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.20.17"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000024267.71656.0d"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115260"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.6.621"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00516.2006"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/7.1.104"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000182697.39687.34"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.04.006"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.109.206318"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(02)00149-1"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5407.1544"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00213.2005"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000105624.68174.00"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.01.013"},{"issue":"4","key":"e_1_3_4_22_2","first-page":"R764","article-title":"Sustained hyperinsulinemia increases arterial pressure in conscious rats.","volume":"260","author":"Brands MW","year":"1991","unstructured":"Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol. 1991;260(4 pt 2):R764\u2013R768.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.5.994"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(95)00118-9"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000123073.48855.e9"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2001000900008"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.109.853077"},{"key":"e_1_3_4_28_2","first-page":"F357","article-title":"Renal autoregulation: perspectives from whole kidney and single nephron studies.","volume":"234","author":"Navar LG","year":"1978","unstructured":"Navar LG. Renal autoregulation: perspectives from whole kidney and single nephron studies. Am J Physiol. 1978;234:F357\u2013F370.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01111.2009"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.1_Suppl.I45"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.9"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1261211"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.168427"},{"issue":"5","key":"e_1_3_4_35_2","first-page":"E717","article-title":"Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans.","volume":"266","author":"Hogikyan RV","year":"1994","unstructured":"Hogikyan RV, Supiano MA. Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol. 1994;266(5 pt 1):E717\u2013E724.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199005000-00014"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.23.6.1012"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.5.2035"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.9.3375"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.107.108126"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.23.13176"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.2.264"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000049620.70909.2e"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.175752"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000104524.25807.ee"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.163931"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.112.196295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:50:41Z","timestamp":1715579441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.112.196295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.112.196295"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.112.196295","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717962759.793464714","asserted-by":"object"}]},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"2012-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-10-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}